FDA.reportPublic FDA data

Application 089406

Type
ANDA
Sponsor
FRESENIUS KABI USA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001POLOCAINE-MPFMEPIVACAINE HYDROCHLORIDEINJECTABLE;INJECTION1%NoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
51662-1403POLOCAINE(R) -MPF (MEPIVACAINE HCI)POLOCAINE(R) -MPF (MEPIVACAINE HCI)HF Acquisition Co LLC, DBA HealthFirstANDACurrent
51662-1403POLOCAINE(R) -MPF (MEPIVACAINE HCI)POLOCAINE(R) -MPF (MEPIVACAINE HCI)HF Acquisition Co LLC, DBA HealthFirstANDACurrent
51662-1403POLOCAINE(R) -MPF (MEPIVACAINE HCI)POLOCAINE(R) -MPF (MEPIVACAINE HCI)HF Acquisition Co LLC, DBA HealthFirstANDACurrent
63323-260Polocaine-MPFMEPIVACAINE HYDROCHLORIDEFresenius Kabi USA, LLCANDACurrent
63323-260Polocaine-MPFMEPIVACAINE HYDROCHLORIDEFresenius Kabi USA, LLCANDACurrent
63323-260Polocaine-MPFMEPIVACAINE HYDROCHLORIDEFresenius Kabi USA, LLCANDACurrent